BR0311874A - Uso de nefopam para o tratamento de náusea ou emese - Google Patents

Uso de nefopam para o tratamento de náusea ou emese

Info

Publication number
BR0311874A
BR0311874A BR0311874-6A BR0311874A BR0311874A BR 0311874 A BR0311874 A BR 0311874A BR 0311874 A BR0311874 A BR 0311874A BR 0311874 A BR0311874 A BR 0311874A
Authority
BR
Brazil
Prior art keywords
nefopam
emesis
treat nausea
nausea
treatment
Prior art date
Application number
BR0311874-6A
Other languages
English (en)
Inventor
Robin Mark Bannister
Michael Harvey Lyne
Original Assignee
Arakis Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Arakis Ltd filed Critical Arakis Ltd
Publication of BR0311874A publication Critical patent/BR0311874A/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/5545—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having eight-membered rings not containing additional condensed or non-condensed nitrogen-containing 3-7 membered rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/06—Antimigraine agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pain & Pain Management (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Hospice & Palliative Care (AREA)
  • Otolaryngology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

"USO DE NEFOPAM PARA O TRATAMENTO DE NáUSEA OU EMESE". A invenção se refere ao uso de nefopam para a preparação de um medicamento para o tratamento de náusea, tonteira, visão turva e emese.
BR0311874-6A 2002-06-17 2003-06-17 Uso de nefopam para o tratamento de náusea ou emese BR0311874A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB0213869.1A GB0213869D0 (en) 2002-06-17 2002-06-17 The treatment of pain
PCT/GB2003/002586 WO2003105832A1 (en) 2002-06-17 2003-06-17 Use of nefopam for the treatment of nausea or emesis

Publications (1)

Publication Number Publication Date
BR0311874A true BR0311874A (pt) 2005-05-10

Family

ID=9938718

Family Applications (1)

Application Number Title Priority Date Filing Date
BR0311874-6A BR0311874A (pt) 2002-06-17 2003-06-17 Uso de nefopam para o tratamento de náusea ou emese

Country Status (15)

Country Link
US (2) US20060063753A1 (pt)
EP (2) EP1513518A1 (pt)
JP (2) JP2005533784A (pt)
CN (1) CN100482221C (pt)
AU (2) AU2003240113B2 (pt)
BR (1) BR0311874A (pt)
CA (2) CA2489306A1 (pt)
GB (1) GB0213869D0 (pt)
IL (1) IL165773A0 (pt)
MX (1) MXPA04012826A (pt)
NO (1) NO20045496L (pt)
NZ (1) NZ537197A (pt)
PL (1) PL374418A1 (pt)
WO (2) WO2003105833A1 (pt)
ZA (1) ZA200410102B (pt)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0330049D0 (en) * 2003-12-24 2004-02-04 Arakis Ltd The treatment of neuropathic pain conditions
GB0408864D0 (en) * 2004-04-21 2004-05-26 Arakis Ltd Novel benzoxazocines
GB0515703D0 (en) * 2005-07-29 2005-09-07 Arakis Ltd Therapeutic use of nefopam
CA2962043A1 (en) * 2007-06-22 2008-12-31 Hydra Biosciences, Inc. Xanthine derivatives for the treatment of diseases mediated by trpa1
GB0721013D0 (en) 2007-10-25 2007-12-05 Sosei R & D Ltd New Salts
CN102046170B (zh) 2008-05-27 2012-11-28 墨尔本大学 治疗患有咽鼓管功能障碍的哺乳动物的方法
US20110092493A1 (en) * 2008-09-24 2011-04-21 Clark Levi Dose-controlled transdermal promethazine compositions and methods of use
RU2608458C2 (ru) * 2009-05-20 2017-01-18 Инсерм (Энститю Насьональ Де Ля Сантэ Э Де Ля Решерш Медикаль) Антагонисты серотониновых 5-нт3-рецепторов для применения при лечении вестибулярных нарушений с повреждениями
EP2512468B1 (en) * 2009-12-15 2016-08-24 The Hospital for Sick Children METHOD OF TREATING SCARS AND ß-CATENIN-MEDIATED DISORDERS USING NEFOPAM COMPOUNDS
EP4335508A3 (en) 2016-04-14 2024-07-10 Sensorion (+)-azasetron for use in the treatment of ear disorders
US10736905B1 (en) 2016-09-09 2020-08-11 Shahin Fatholahi Nefopam dosage forms and methods of treatment
US10736874B1 (en) 2017-09-08 2020-08-11 Shahin Fatholahi Methods for treating pain associated with sickle cell disease
US11446311B2 (en) 2017-09-08 2022-09-20 Shahin Fatholahi Methods for treating pain associated with sickle cell disease
RS65140B1 (sr) * 2019-05-06 2024-02-29 Chemcom Sa Upotreba kompozicije protiv neprijatnih mirisa i povezani postupak

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2338753C (en) * 1998-07-24 2006-11-21 Jago Research Ag Medicinal aerosol formulations
US20020013331A1 (en) * 2000-06-26 2002-01-31 Williams Robert O. Methods and compositions for treating pain of the mucous membrane

Also Published As

Publication number Publication date
AU2003277077B2 (en) 2006-11-02
GB0213869D0 (en) 2002-07-31
ZA200410102B (en) 2006-07-26
CN100482221C (zh) 2009-04-29
CA2489315A1 (en) 2003-12-24
WO2003105833A1 (en) 2003-12-24
PL374418A1 (en) 2005-10-17
EP1513518A1 (en) 2005-03-16
AU2003240113B2 (en) 2006-11-16
CN1668294A (zh) 2005-09-14
IL165773A0 (en) 2006-01-15
AU2003277077A1 (en) 2003-12-31
CA2489306A1 (en) 2003-12-24
US20060040905A1 (en) 2006-02-23
US20060063753A1 (en) 2006-03-23
MXPA04012826A (es) 2005-03-31
AU2003240113A1 (en) 2003-12-31
NO20045496L (no) 2005-01-12
WO2003105832A1 (en) 2003-12-24
EP1513517A1 (en) 2005-03-16
NZ537197A (en) 2007-10-26
JP2005531612A (ja) 2005-10-20
JP2005533784A (ja) 2005-11-10

Similar Documents

Publication Publication Date Title
BR0311874A (pt) Uso de nefopam para o tratamento de náusea ou emese
BR0213358A (pt) Uso de flibanserina
DOP2002000429A (es) Imidazotriazinas
BR0207760A (pt) Composição farmacêutica, uso da mesma, métodos para o tratamento de dor e de inflamação, e, processo para a preparação de uma composição
ATE457171T1 (de) Kombinationstherapie substituierter oxazolidinone
WO2003009838A1 (fr) Utilisation de composes de stilbene dans la preparation de medicaments pour le traitement ou la prevention du diabete et des maladies associees au retrovirus
PT1052905E (pt) Processo anti-germinativo de tuberculos e bolbos utilizando o eugenol e/ou o isoeugenol
WO2001060347A3 (en) Method for treating ocular pain
CL2004000551A1 (es) Compuestos derivados de triazol sustituidos con biarilo, sus sales, bloqueadores del canal de sodio; procedimiento de preparacion; composicion farmaceutica; y su uso en el tratamiento o prevencion del dolor.
DK1056454T3 (da) Anvendelse af makrolidforbindelser til behandling af glaukom
WO2003002064A3 (en) Fused pyrimidine dhfr inhibitors as antibacterials
BRPI0417175A (pt) composições, método para produzir essas composições, solução que as compreende e métodos para utilizar as mesmas
PT1228028E (pt) Sais de hidroxieicosatetraeniato, composicoes e metodos para utilizacao no tratamento de perturbacoes da secura ocular
DE60128100D1 (de) Analgetisches arzneimittel
NO20033318D0 (no) 2H-1-benzopyranderivater, fremgangsmåte ved fremstilling samt farmasöytiskesammensetninger derav
WO2001040473A3 (en) Pseudomonas aeruginosa antigens
ES2177024T3 (es) Empleo de la fanquinoma para el tratamiento de la enfermedaad de alzheimer.
WO1999051256A3 (en) Use of l-glu-l-trp in the treatment of hiv infection
WO2002070638A3 (en) Essential oil from.coleus forskohlii, production process and use as antimicrobial agent
HK1065305A1 (en) Substituted 4-aminocyclohexanol derivatives
SE0000303D0 (sv) Novel compounds
WO2003042240A3 (en) Polypeptides of pseudomonas aeruginosa
DE60108354D1 (de) 2H-1-Benzopyran-Derivative, Prozesse zu ihrer Herstellung und Pharmazeutische Zusammensetzungen
DK1523985T3 (da) Ikke-radioaktivt strontiumholdigt middel til behandling af kræft
DK0865436T3 (da) Dithiazoldioxider samt deres anvendelse som mikrobicider

Legal Events

Date Code Title Description
B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE 8A. ANUIDADE(S).

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: NAO APRESENTADA A GUIA DE CUMPRIMENTO DE EXIGENCIA. REFERENTE A 8A ANUIDADE.